Back

PharmaEssentia leads Taiwan 50 ETF reshuffle ahead of September 4 review

Verifying
  • PharmaEssentia leads candidates for inclusion in the Taiwan 50 Index.
  • PharmaEssentia ranked 34th with an 89.77% public float ratio on August 24, 2026.
  • FTSE Russell will release final quarterly review results on September 4.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.